328 related articles for article (PubMed ID: 31788764)
1. A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug-Drug Interactions with Orally Administered Medications.
Patel D; Bertz R; Ren S; Boulton DW; Någård M
Clin Pharmacokinet; 2020 Apr; 59(4):447-462. PubMed ID: 31788764
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of US Food and Drug Administration Drug Label Recommendations for Coadministration of Antivirals and Acid-Reducing Agents.
Shugg T; Powell NR; Marroum PJ; Skaar TC; Younis IR
Clin Pharmacol Ther; 2022 Nov; 112(5):1088-1097. PubMed ID: 35920069
[TBL] [Abstract][Full Text] [Related]
3. Clinically significant drug interactions with antacids: an update.
Ogawa R; Echizen H
Drugs; 2011 Oct; 71(14):1839-64. PubMed ID: 21942976
[TBL] [Abstract][Full Text] [Related]
4. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
5. pH-dependent drug-drug interactions for weak base drugs: potential implications for new drug development.
Zhang L; Wu F; Lee SC; Zhao H; Zhang L
Clin Pharmacol Ther; 2014 Aug; 96(2):266-77. PubMed ID: 24733008
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development.
Smelick GS; Heffron TP; Chu L; Dean B; West DA; Duvall SL; Lum BL; Budha N; Holden SN; Benet LZ; Frymoyer A; Dresser MJ; Ware JA
Mol Pharm; 2013 Nov; 10(11):4055-62. PubMed ID: 24044612
[TBL] [Abstract][Full Text] [Related]
7. Consistent gastric pH-dependent effects of suppressors of gastric acid secretion on the antihypertensive responses to oral nitrite.
Sanches-Lopes JM; Ferreira GC; Pinheiro LC; Kemp R; Tanus-Santos JE
Biochem Pharmacol; 2020 Jul; 177():113940. PubMed ID: 32224135
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for the effect of acid-reducing agents on drug exposure.
Sato M; Narukawa M
Int J Clin Pharmacol Ther; 2017 Oct; 55(10):798-806. PubMed ID: 28766497
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pH-Dependent Drug-Drug Interactions for Basic Drugs Using Physiologically Based Biopharmaceutics Modeling: Industry Case Studies.
Mitra A; Parrott N; Miller N; Lloyd R; Tistaert C; Heimbach T; Ji Y; Kesisoglou F
J Pharm Sci; 2020 Mar; 109(3):1380-1394. PubMed ID: 31778721
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.
Gay C; Toulet D; Le Corre P
Hematol Oncol; 2017 Sep; 35(3):259-280. PubMed ID: 27925256
[TBL] [Abstract][Full Text] [Related]
12. Application of Physiologically-Based Pharmacokinetic Modeling to Predict Gastric pH-Dependent Drug-Drug Interactions for Weak Base Drugs.
Dong Z; Li J; Wu F; Zhao P; Lee SC; Zhang L; Seo P; Zhang L
CPT Pharmacometrics Syst Pharmacol; 2020 Aug; 9(8):456-465. PubMed ID: 32633893
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of pregnancy-related clinical intervention of drug regimens due to pharmacokinetic reasons.
Borda LA; Någård M; Boulton DW; Venkataramanan R; Coppola P
Front Med (Lausanne); 2023; 10():1241456. PubMed ID: 38093976
[TBL] [Abstract][Full Text] [Related]
14. Drug-Drug Interactions With Over-The-Counter Medicines: Mind the Unprescribed.
Scherf-Clavel O
Ther Drug Monit; 2022 Apr; 44(2):253-274. PubMed ID: 34469416
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug-drug interactions in cancer patients treated at a university hospital in North Cyprus using two interaction databases.
Laban AA; Birand N; Chukwunyere U; Abdi A; Basgut B
Niger J Clin Pract; 2021 Jul; 24(7):1067-1071. PubMed ID: 34290184
[TBL] [Abstract][Full Text] [Related]
16. Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors.
Willemsen AE; Lubberman FJ; Tol J; Gerritsen WR; van Herpen CM; van Erp NP
Drug Discov Today; 2016 Jun; 21(6):962-76. PubMed ID: 26995271
[TBL] [Abstract][Full Text] [Related]
17. Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions.
Sun W; Klamerus KJ; Yuhas LM; Pawlak S; Plotka A; O'Gorman M; Kirkovsky L; Kosa M; Wang D
Clin Pharmacol Drug Dev; 2017 Nov; 6(6):614-626. PubMed ID: 28430398
[TBL] [Abstract][Full Text] [Related]
18. Effect of gastric acid-reducing agents on the pharmacokinetics and efficacy of lemborexant.
Landry I; Aluri J; Hall N; Kumar D; Dayal S; Moline M; Reyderman L
Pharmacol Res Perspect; 2020 Dec; 8(6):e00678. PubMed ID: 33135390
[TBL] [Abstract][Full Text] [Related]
19. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
Costarino AT; Dai D; Feng R; Feudtner C; Guevara JP
Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
[TBL] [Abstract][Full Text] [Related]
20. Application of Solubility and Dissolution Profile Comparison for Prediction of Gastric pH-Mediated Drug-Drug Interactions.
Miao L; Wu F; Yang X; Mousa YM; Ramamoorthy A; Lee SC; Raines K; Zhang L; Seo P
AAPS J; 2022 Feb; 24(1):35. PubMed ID: 35165814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
